Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000478297 | SCV000572454 | uncertain significance | not provided | 2023-05-07 | criteria provided, single submitter | clinical testing | Not observed in any cases, but was observed in unaffected controls from a breast cancer study (Momozawa et al., 2018); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this variant does not alter splicing; Also known as 3083A>G; This variant is associated with the following publications: (PMID: 30287823) |
Ambry Genetics | RCV001017690 | SCV001178811 | likely benign | Hereditary cancer-predisposing syndrome | 2015-10-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001174661 | SCV001337877 | likely benign | not specified | 2020-01-05 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001017690 | SCV001341497 | likely benign | Hereditary cancer-predisposing syndrome | 2018-06-13 | criteria provided, single submitter | clinical testing | |
Invitae | RCV002063812 | SCV002479616 | likely benign | Hereditary breast ovarian cancer syndrome | 2023-07-25 | criteria provided, single submitter | clinical testing |